"Name","Code","Type_","Period_","STMTYPECODE","ITEM","COA","Value_","Desc_","Unit","IsCurrency","Consolidated"
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,1,RNTS,16941.0,Net Sales,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,10,SREV,16941.0,Revenue,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,31,RTLR,16941.0,Total Revenue,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,34,ECOR,7629.1,Cost of Revenue,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,36,SCOR,7629.1,"Cost of Revenue, Total",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,37,SGRP,9311.9,Gross Profit,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,52,ESGA,1546.2,Selling/General/Administrative Expense,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,53,ELAR,1504.9,Labor & Related Expense,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,55,SSGA,3051.1,"Selling/General/Admin. Expenses, Total",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,56,ERAD,737.2,Research & Development,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,57,EDEP,509.8,Depreciation,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,58,EAMI,24.6,Amortization of Intangibles,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,60,SDPR,534.4,Depreciation/Amortization,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,83,ETOE,11951.8,Total Operating Expense,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,84,SOPI,4989.2,Operating Income,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,85,NIEN,-7.8,Interest Expense - Non-Operating,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,87,SIEN,-7.8,"Interest Expense, Net Non-Operating",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,88,NIIN,472.8,Interest Income - Non-Operating,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,89,NINV,144.8,Investment Income - Non-Operating,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,90,SIIN,617.6,Interest/Invest Income -  Non-Operating,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,92,NGLA,-6.5,Gain (Loss) on Sale of Assets,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,126,NONT,51.8,Other Non-Operating Income (Expense),M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,127,SONT,51.8,"Other, Net",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,128,EIBT,5644.3,Net Income Before Taxes,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,129,TTAX,1030.1,Provision for Income Taxes,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,130,TIAT,4614.2,Net Income After Taxes,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,131,CMIN,-43.3,Minority Interest,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,134,NIBX,4570.9,Net Income Before Extra. Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,140,NINC,4570.9,Net Income,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,147,CIAC,4570.9,Income Available to Com Excl ExtraOrd,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,148,XNIC,4570.9,Income Available to Com Incl ExtraOrd,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,149,SBAS,75.93549,Basic Weighted Average Shares,M,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,150,SBBF,60.19452,Basic EPS Excluding Extraordinary Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,151,SBAI,60.19452,Basic EPS Including Extraordinary Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,153,SDNI,4570.9,Diluted Net Income,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,154,SDWS,76.30931,Diluted Weighted Average Shares,M,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,155,SDBF,59.89964,Diluted EPS Excluding ExtraOrd Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,156,SDAI,59.89964,Diluted EPS Including ExtraOrd Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,157,DDPS1,5.0,DPS - Common Stock Primary Issue,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,171,VIEX,7.8,"Interest Expense, Supplemental",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,173,VDEP,509.8,"Depreciation, Supplemental",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,175,STSI,6.5,Total Special Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,176,VPTI,5650.8,Normalized Income Before Taxes,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,177,STEC,1.18627,Effect of Special Items on Income Taxes,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,178,VITN,1031.28627,Inc Tax Ex Impact of Sp Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,179,VIAT,4619.51373,Normalized Income After Taxes,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,180,VIAC,4576.21373,Normalized Inc. Avail to Com.,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,181,VBES,60.26449,Basic Normalized EPS,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,182,VDES,59.96927,Diluted Normalized EPS,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,184,VAMI,24.6,"Amort of Intangibles, Supplemental",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,185,VRXP,94.0,"Rental Expense, Supplemental",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,188,VEIA,2.7,"Equity in Affiliates, Supplemental",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,189,VMIN,-43.3,"Minority Interest, Supplemental",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,190,VRAD,766.1,"Research & Development Exp, Supplemental",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,191,VTAU,6.3,Audit Fees,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,193,VTTF,2.4,Tax Fees,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,194,VTOF,0.0,All Other Fees,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,209,SGPP,54.96665,Gross Margin,M,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,210,SOPP,29.45045,Operating Margin,M,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,211,SPTM,33.3174,Pretax Margin,M,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,212,SETR,18.25027,Effective Tax Rate,M,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,213,SNPM,26.98129,Net Profit Margin,M,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,214,SBIT,4989.2,Normalized EBIT,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,215,SBDA,5523.6,Normalized EBITDA,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,221,VCTR,1015.5,Current Tax - Total,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,222,VCTC,1015.5,Current Tax - Total,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,227,VDTR,14.6,Deferred Tax - Total,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,228,VDTC,14.6,Deferred Tax - Total,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,233,VITT,1030.1,Income Tax - Total,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,240,VSCD,22.5,Service Cost - Domestic,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,241,VTPS,0.0,Prior Service Cost - Domestic,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,247,VDPP,23.2,Domestic Pension Plan Expense,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,266,VDCD,44.9,Defined Contribution Expense - Domestic,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,269,VTPE,68.1,Total Pension Expense,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,283,STPS,22.5,Total Plan Service Cost,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,999,SNIN,609.8,"Interest Inc.(Exp.),Net-Non-Op., Total",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,1068,VLAR,1504.9,Labor & Related Expense Suppl.,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,1078,VDNI,0.7,Net Interest Cost - Domestic,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,1130,VDRU,12.6,"Depreciation of Right-of-Use Assets,Sup.",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",1,1132,VIEL,1.6,"Interest Expense on Lease Liabs., Suppl.",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,834,ONET,5644.3,Net Income/Starting Line,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,835,SDEP,534.4,Depreciation,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,837,SDED,534.4,Depreciation/Depletion,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,846,OUIE,-22.5,Unusual Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,848,OEIA,-2.7,Equity in Net Earnings (Loss),M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,849,ONCI,-485.2,Other Non-Cash Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,850,SNCI,-510.4,Non-Cash Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,853,SCTP,1090.0,Cash Taxes Paid,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,854,SCIP,7.8,Cash Interest Paid,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,856,OACR,-1486.6,Accounts Receivable,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,857,OITL,-748.2,Inventories,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,859,OOAS,-47.4,Other Assets,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,860,OAPB,773.0,Accounts Payable,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,865,OOAL,114.8,"Other Assets & Liabilities, Net",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,866,OOCF,-1090.0,Other Operating Cash Flow,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,880,SOCF,-2484.4,Changes in Working Capital,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,881,OTLO,3183.9,Cash from Operating Activities,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,882,ICEX,-1458.2,Purchase of Fixed Assets,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,885,SCEX,-1458.2,Capital Expenditures,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,889,IINS,20.3,Sale/Maturity of Investment,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,890,IIVN,-933.9,"Investment, Net",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,899,IICF,-828.6,Other Investing Cash Flow,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,900,SICF,-1742.2,"Other Investing Cash Flow Items, Total",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,901,ITLI,-3200.4,Cash from Investing Activities,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,905,FFCF,-7.8,Other Financing Cash Flow,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,906,SFCF,-7.8,Financing Cash Flow Items,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,907,FDPC,-341.7,Cash Dividends Paid - Common,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,909,FCDP,-341.7,Total Cash Dividends Paid,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,918,FOPX,0.1,Options Exercised,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,921,FPSS,0.1,"Issuance (Retirement) of Stock, Net",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,930,FPRD,-31.3,"Issuance (Retirement) of Debt, Net",M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,931,FTLF,-380.7,Cash from Financing Activities,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,932,SFEE,8.6,Foreign Exchange Effects,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,933,SNCC,-388.6,Net Change in Cash,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,934,SNCB,1775.6,Net Cash - Beginning Balance,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,935,SNCE,1387.0,Net Cash - Ending Balance,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",2,1140,SCWC,-1394.4,Net Changes in Working Capital,M,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,436,ACSH,895.2,Cash, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,437,ACAE,490.3,Cash & Equivalents, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,438,ASTI,6421.5,Short Term Investments, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,439,SCSI,7807.0,Cash and Short Term Investments, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,440,AARG,5623.6,"Accounts Receivable - Trade, Gross", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,442,AACR,5623.6,"Accounts Receivable - Trade, Net", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,444,AORC,1744.5,Receivables - Other, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,445,ATRC,7368.1,"Total Receivables, Net", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,446,AIFG,2761.2,Inventories - Finished Goods, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,447,AIWP,68.1,Inventories - Work In Progress, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,448,AIRM,406.5,Inventories - Raw Materials, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,449,AIOT,394.6,Inventories - Other, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,453,AITL,3630.4,Total Inventory, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,454,APPY,18.0,Prepaid Expenses, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,455,ARCA,100.2,Restricted Cash - Current, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,460,AOCA,5.5,Other Current Assets, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,461,SOCA,105.7,"Other Current Assets, Total", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,462,ATCA,18929.2,Total Current Assets, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,480,APBC,1452.0,Buildings - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,481,ALIC,238.1,Land/Improvements - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,482,AMEC,3160.4,Machinery/Equipment - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,483,ACPC,1166.2,Construction in Progress - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,484,APLC,140.4,Leases - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,486,AOPC,1806.2,Other Property/Plant/Equipment - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,487,APTC,7963.3,"Property/Plant/Equipment, Total - Gross", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,488,ADEP,-2395.7,"Accumulated Depreciation, Total", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,489,APPN,5567.6,"Property/Plant/Equipment, Total - Net", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,490,AGWG,27.7,Goodwill - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,491,AAGA,0.0,Accumulated Goodwill Amortization, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,492,AGWI,27.7,"Goodwill, Net", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,493,AING,198.3,Intangibles - Gross, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,494,AAMT,-100.8,Accumulated Intangible Amortization, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,495,AINT,97.5,"Intangibles, Net", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,503,ALTI,1376.4,LT Investments - Other, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,504,SINV,1376.4,Long Term Investments, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,506,ALTR,182.0,Note Receivable - Long Term, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,507,ADFC,623.2,Deferred Charges, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,509,ADTA,125.5,Defered Income Tax - Long Term Asset, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,512,AOAS,52.1,Other Long Term Assets, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,513,SOLA,800.8,"Other Long Term Assets, Total", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,523,ATOT,26981.2,Total Assets, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,524,LAPB,2094.1,Accounts Payable, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,526,LAEX,253.0,Accrued Expenses, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,547,LSTD,0.0,Notes Payable/Short Term Debt, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,548,LCLD,10.5,Current Port. of  LT Debt/Capital Leases, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,549,LDPB,24.7,Dividends Payable, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,550,LCAV,308.1,Customer Advances, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,553,LOPB,502.5,Other Payables, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,556,LOCL,119.9,Other Current Liabilities, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,557,SOCL,955.2,"Other Current liabilities, Total", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,558,LTCL,3312.8,Total Current Liabilities, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,560,LCLO,9.2,Capital Lease Obligations, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,561,LTTD,9.2,Total Long Term Debt, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,562,STLD,19.7,Total Debt, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,566,LMIN,311.2,Minority Interest, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,567,LRSV,86.1,Reserves, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,569,LLTL,104.8,Other Long Term Liabilities, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,572,SLTL,190.9,"Other Liabilities, Total", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,573,LTLL,3824.1,Total Liabilities, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,582,QCMS,151.9,Common Stock, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,584,SCMS,151.9,"Common Stock, Total", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,585,QPIC,154.1,Additional Paid-In Capital, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,586,QRED,19772.1,Retained Earnings (Accumulated Deficit), ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,588,QEDG,142.2,ESOP Debt Guarantee, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,589,QUGL,745.8,Unrealized Gain (Loss), ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,590,QCTA,0.8,Translation Adjustment, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,591,QOTE,1419.9,Other Equity, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,593,QCOM,770.3,Other Comprehensive Income, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,594,SOTE,2191.0,"Other Equity, Total", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,595,QTLE,23157.1,Total Equity, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,596,QTEL,26981.2,Total Liabilities & Shareholders' Equity, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,597,QCSO1,75.94175,Shares Outs - Common Stock Primary Issue, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,601,QTCO,75.94175,Total Common Shares Outstanding, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,602,QTSN1,0.0,Treas Shares - Common Stock Prmry Issue, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,619,METL,859.0,Employees, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,621,MNOS,81409.0,Number of Common Shareholders, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,622,VAGA,0.0,Accumulated Goodwill Amortization Suppl., ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,623,VAIA,100.8,"Accumulated Intangible Amort, Suppl.", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,624,VADC,308.1,Deferred Revenue - Current, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,625,VADL,28.7,Deferred Revenue - Long Term, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,633,SCUI,15298.8,Total Current Assets less Inventory, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,634,SQCK,4.61809,Quick Ratio, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,635,SCUR,5.71396,Current Ratio, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,636,SNTD,-7476.1,Net Debt, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,637,STBV,23031.9,Tangible Book Value, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,638,STBP,303.28377,Tangible Book Value per Share, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,663,VTCL,16.9,"Total Capital Leases, Supplemental", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,664,SCL1,7.7,Capital Lease Payments Due in Year 1, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,665,SCL2,9.2,Capital Lease Payments Due in Year 2, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,666,SCL3,0.0,Capital Lease Payments Due in Year 3, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,667,SCL4,0.0,Capital Lease Payments Due in Year 4, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,668,SCL5,0.0,Capital Lease Payments Due in Year 5, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,674,SCL23,9.2,Capital Lease Payments Due in 2-3 Years, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,675,SCL45,0.0,Capital Lease Payments Due in 4-5 Years, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,676,SCL6B,0.0,Cap. Lease Pymts. Due in Year 6 & Beyond, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,691,VAPD,112.7,Pension Obligation - Domestic, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,694,VPAD,105.4,Plan Assets - Domestic, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,697,VPPD,-7.3,Funded Status - Domestic, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,704,VFSS,-7.3,Total Funded Status, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,705,VDRD,7.09,Discount Rate - Domestic, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,708,VERD,7.0,Expected Rate of Return - Domestic, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,711,VRCD,7.0,Compensation Rate - Domestic, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,723,VALD,-7.3,Accrued Liabilities - Domestic, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,732,VARS,-7.3,Net Assets Recognized on Balance Sheet, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,749,STPO,112.7,Total Plan Obligations, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,750,STPA,105.4,Total Plan Assets, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,804,MPRE,39.0,Number of Products in Pre-Registration, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,805,MPPL,9.0,Number of Products Launched, ,0,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,1056,QTLL,23468.3,Total Equity & Minority Interest, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,1057,VMNR,311.2,Minority Interest - Non Redeemable, ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,1123,VLCC,7.7,"Curr. Port. of LT Capital Leases, Suppl.", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,1124,VUCD,15.1,"Right-of-Use Assets-Cap.Lease,Depr.-Sup.", ,1,1
Caplin Point Laboratories Ltd,74096,1,"2024-03-31",3,1128,VUCG,30.3,"Right-of-Use Assets-Cap.Lease,Gross-Sup.", ,1,1
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,1,RNTS,6250.9,Net Sales,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,10,SREV,6250.9,Revenue,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,31,RTLR,6250.9,Total Revenue,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,34,ECOR,2052.2,Cost of Revenue,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,36,SCOR,2052.2,"Cost of Revenue, Total",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,37,SGRP,4198.7,Gross Profit,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,53,ELAR,381.1,Labor & Related Expense,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,55,SSGA,381.1,"Selling/General/Admin. Expenses, Total",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,56,ERAD,287.4,Research & Development,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,57,EDEP,259.6,Depreciation,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,58,EAMI,11.2,Amortization of Intangibles,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,60,SDPR,270.8,Depreciation/Amortization,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,80,EOOE,653.3,Other Operating Expense,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,82,SOOE,653.3,"Other Operating Expenses, Total",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,83,ETOE,3644.8,Total Operating Expense,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,84,SOPI,2606.1,Operating Income,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,85,NIEN,-1.0,Interest Expense - Non-Operating,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,87,SIEN,-1.0,"Interest Expense, Net Non-Operating",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,89,NINV,29.0,Investment Income - Non-Operating,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,90,SIIN,29.0,Interest/Invest Income -  Non-Operating,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,92,NGLA,-4.7,Gain (Loss) on Sale of Assets,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,126,NONT,1028.0,Other Non-Operating Income (Expense),M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,127,SONT,1028.0,"Other, Net",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,128,EIBT,3657.4,Net Income Before Taxes,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,129,TTAX,820.3,Provision for Income Taxes,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,130,TIAT,2837.1,Net Income After Taxes,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,134,NIBX,2837.1,Net Income Before Extra. Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,140,NINC,2837.1,Net Income,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,147,CIAC,2837.1,Income Available to Com Excl ExtraOrd,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,148,XNIC,2837.1,Income Available to Com Incl ExtraOrd,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,149,SBAS,75.93549,Basic Weighted Average Shares,M,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,150,SBBF,37.36198,Basic EPS Excluding Extraordinary Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,151,SBAI,37.36198,Basic EPS Including Extraordinary Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,153,SDNI,2837.1,Diluted Net Income,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,154,SDWS,76.30931,Diluted Weighted Average Shares,M,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,155,SDBF,37.17895,Diluted EPS Excluding ExtraOrd Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,156,SDAI,37.17895,Diluted EPS Including ExtraOrd Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,157,DDPS1,5.0,DPS - Common Stock Primary Issue,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,171,VIEX,1.0,"Interest Expense, Supplemental",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,173,VDEP,259.6,"Depreciation, Supplemental",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,175,STSI,4.7,Total Special Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,176,VPTI,3662.1,Normalized Income Before Taxes,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,177,STEC,1.05414,Effect of Special Items on Income Taxes,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,178,VITN,821.35414,Inc Tax Ex Impact of Sp Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,179,VIAT,2840.74586,Normalized Income After Taxes,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,180,VIAC,2840.74586,Normalized Inc. Avail to Com.,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,181,VBES,37.40999,Basic Normalized EPS,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,182,VDES,37.22673,Diluted Normalized EPS,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,184,VAMI,11.2,"Amort of Intangibles, Supplemental",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,190,VRAD,287.4,"Research & Development Exp, Supplemental",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,209,SGPP,67.16953,Gross Margin,M,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,210,SOPP,41.6916,Operating Margin,M,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,211,SPTM,58.50997,Pretax Margin,M,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,212,SETR,22.4285,Effective Tax Rate,M,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,213,SNPM,45.38706,Net Profit Margin,M,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,214,SBIT,2606.1,Normalized EBIT,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,215,SBDA,2876.9,Normalized EBITDA,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,221,VCTR,861.2,Current Tax - Total,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,222,VCTC,861.2,Current Tax - Total,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,227,VDTR,-40.9,Deferred Tax - Total,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,228,VDTC,-40.9,Deferred Tax - Total,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,233,VITT,820.3,Income Tax - Total,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,999,SNIN,28.0,"Interest Inc.(Exp.),Net-Non-Op., Total",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,1068,VLAR,381.1,Labor & Related Expense Suppl.,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,1130,VDRU,7.3,"Depreciation of Right-of-Use Assets,Sup.",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",1,1132,VIEL,1.0,"Interest Expense on Lease Liabs., Suppl.",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,834,ONET,3657.4,Net Income/Starting Line,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,835,SDEP,270.8,Depreciation,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,837,SDED,270.8,Depreciation/Depletion,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,846,OUIE,-24.3,Unusual Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,849,ONCI,-932.2,Other Non-Cash Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,850,SNCI,-956.5,Non-Cash Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,853,SCTP,870.9,Cash Taxes Paid,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,854,SCIP,1.0,Cash Interest Paid,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,856,OACR,-404.3,Accounts Receivable,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,857,OITL,-347.2,Inventories,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,859,OOAS,6.3,Other Assets,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,860,OAPB,-245.5,Accounts Payable,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,866,OOCF,-870.9,Other Operating Cash Flow,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,880,SOCF,-1861.6,Changes in Working Capital,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,881,OTLO,1110.1,Cash from Operating Activities,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,882,ICEX,-230.7,Purchase of Fixed Assets,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,885,SCEX,-230.7,Capital Expenditures,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,889,IINS,3.5,Sale/Maturity of Investment,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,890,IIVN,-981.5,"Investment, Net",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,899,IICF,19.3,Other Investing Cash Flow,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,900,SICF,-958.7,"Other Investing Cash Flow Items, Total",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,901,ITLI,-1189.4,Cash from Investing Activities,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,905,FFCF,-1.0,Other Financing Cash Flow,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,906,SFCF,-1.0,Financing Cash Flow Items,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,907,FDPC,-341.7,Cash Dividends Paid - Common,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,909,FCDP,-341.7,Total Cash Dividends Paid,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,918,FOPX,0.1,Options Exercised,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,921,FPSS,0.1,"Issuance (Retirement) of Stock, Net",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,931,FTLF,-342.6,Cash from Financing Activities,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,932,SFEE,8.1,Foreign Exchange Effects,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,933,SNCC,-413.8,Net Change in Cash,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,934,SNCB,1220.2,Net Cash - Beginning Balance,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,935,SNCE,806.4,Net Cash - Ending Balance,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,1140,SCWC,-990.7,Net Changes in Working Capital,M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",2,1174,VSPY,5.0,"Share Based Payments,  Supplemental",M,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,437,ACAE,2157.8,Cash & Equivalents, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,438,ASTI,2515.9,Short Term Investments, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,439,SCSI,4673.7,Cash and Short Term Investments, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,440,AARG,1286.7,"Accounts Receivable - Trade, Gross", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,442,AACR,1286.7,"Accounts Receivable - Trade, Net", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,445,ATRC,1286.7,"Total Receivables, Net", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,453,AITL,862.5,Total Inventory, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,460,AOCA,208.1,Other Current Assets, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,461,SOCA,208.1,"Other Current Assets, Total", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,462,ATCA,7031.0,Total Current Assets, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,489,APPN,1903.7,"Property/Plant/Equipment, Total - Net", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,495,AINT,31.7,"Intangibles, Net", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,503,ALTI,3563.6,LT Investments - Other, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,504,SINV,3563.6,Long Term Investments, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,506,ALTR,2639.7,Note Receivable - Long Term, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,512,AOAS,53.4,Other Long Term Assets, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,513,SOLA,53.4,"Other Long Term Assets, Total", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,523,ATOT,15223.1,Total Assets, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,524,LAPB,786.2,Accounts Payable, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,547,LSTD,0.0,Notes Payable/Short Term Debt, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,548,LCLD,7.7,Current Port. of  LT Debt/Capital Leases, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,556,LOCL,399.1,Other Current Liabilities, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,557,SOCL,399.1,"Other Current liabilities, Total", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,558,LTCL,1193.0,Total Current Liabilities, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,560,LCLO,1.6,Capital Lease Obligations, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,561,LTTD,1.6,Total Long Term Debt, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,562,STLD,9.3,Total Debt, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,563,LBDT,100.0,Deferred Income Tax - LT Liability, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,565,SBDT,100.0,Deferred Income Tax, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,569,LLTL,27.0,Other Long Term Liabilities, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,572,SLTL,27.0,"Other Liabilities, Total", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,573,LTLL,1321.6,Total Liabilities, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,582,QCMS,151.9,Common Stock, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,584,SCMS,151.9,"Common Stock, Total", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,586,QRED,13749.6,Retained Earnings (Accumulated Deficit), ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,595,QTLE,13901.5,Total Equity, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,596,QTEL,15223.1,Total Liabilities & Shareholders' Equity, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,597,QCSO1,75.94175,Shares Outs - Common Stock Primary Issue, ,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,601,QTCO,75.94175,Total Common Shares Outstanding, ,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,602,QTSN1,0.0,Treas Shares - Common Stock Prmry Issue, ,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,633,SCUI,6168.5,Total Current Assets less Inventory, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,634,SQCK,5.17058,Quick Ratio, ,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,635,SCUR,5.89355,Current Ratio, ,0,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,636,SNTD,-4664.4,Net Debt, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,637,STBV,13869.8,Tangible Book Value, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,638,STBP,182.63735,Tangible Book Value per Share, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,1056,QTLL,13901.5,Total Equity & Minority Interest, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,1060,VINT,31.7,Intangibles - Net, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,1061,VPPN,1903.7,Other Property/Plant/Equipment - Net, ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,1123,VLCC,7.7,"Curr. Port. of LT Capital Leases, Suppl.", ,1,0
Caplin Point Laboratories Ltd (Parent),113136,1,"2024-03-31",3,1126,VUCN,8.5,"Right-of-Use Assets-Cap.Lease,Net-Suppl.", ,1,0
